Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Exscientia
Biotech
After a tough year, Exscientia folds into Recursion
After a tough year, Exscientia will merge into Recursion, creating one company that has 10 clinical readouts expected over the next 18 months.
Annalee Armstrong
Aug 8, 2024 8:54am
Exscientia pays $20M for full control of CDK7 cancer prospect
Jul 18, 2024 10:08am
Sanofi, Lilly, Amarin & more—Chutes & Ladders
Jun 7, 2024 8:30am
Exscientia cuts a quarter of staff while preserving AI pipeline
May 21, 2024 11:17am
Exscientia fires CEO—Chutes & Ladders
Feb 16, 2024 9:30am
Exscientia fires CEO Andrew Hopkins effective immediately
Feb 13, 2024 8:35am
